Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 540

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 540
---
 OSR Holdings for inclusion in the proxy statement for the 2025 annual meeting of stockholders in accordance with Rule 14a -8under the Exchange Act. Delivery of Documents to Stockholders Pursuant to the rules of the SEC, we and servicers that we employ to deliver communications to our stockholders are permitted to deliver to two or more stockholders sharing the same address a single copy of this proxy statement/prospectus. Upon written or oral request, we will deliver a separate copy of this proxy statement/prospectus to any stockholder at a shared address to which a single copy of this proxy statement/prospectus was delivered and who wishes to receive separate copies in the future. Stockholders receiving multiple copies of this proxy statement/prospectus may likewise request that we deliver single copies of any proxy statement/prospectus in the future. Stockholders may notify us of their requests by emailing or writing us at our principal executive offices at group@bellevuecm.com or 10900 NE 4 thStreet, Suite 2300, Bellevue, WA 98004. Transfer Agent and Register The transfer agent for the securities of BLAC is Continental Stock Transfer & Trust Company. LEGAL MATTERS The validity of the shares of BLAC Common Stock to be issued in connection with the Business Combination and the material U.S. federal income tax consequences of the Business Combination will be passed upon by K&L Gates LLP. EXPERTS The financial statements of Bellevue Life Sciences Acquisition Corp. as of December 31, 2023 and 2022 included in this proxy statement/prospectus have been so included in reliance on the report of WithumSmith+Brown, PC, an independent registered public accounting firm, which includes an explanatory paragraph as to the ability of Bellevue Life Sciences Acquisition Corp. to continue as a going concern, upon the authority of said firm as experts in accounting and auditing. The financial statements of OSR Holdings Co., Ltd. as of December31, 2022 and 2023 and Darnatein Co., Ltd. as of December31, 2021 and 2022 included in this proxy statement/prospectus have been so included in reliance upon the report of RSM Shinhan Accounting Corporation independent registered public accountants. 344 WHERE YOU CAN FIND MORE INFORMATION We file reports, proxy statements and other information with the SEC as required by the Exchange Act. You can read BLAC’s SEC filings, including this proxy statement/prospectus, over the Internet at the SEC’s website at